Skip to main content
. 2019 Jun 12:1–19. Online ahead of print. doi: 10.1007/s10787-019-00610-8

Table 3.

Genes predicted to be regulated by IRF1 and IRF7 as identified by IPA analysis in R848- and IFN-α treated PM cells

R848-induced cells IFN-α-induced cells
IRF1 predicted to be activated (35 genes) (P = 2.23E−26) IRF7 predicted to be activated (56 genes) (P = 1.26E−31) IRF1 predicted to be activated (39 genes) (P = 3.23E−29) IRF7 predicted to be activated (42 genes) (P = 4.44E−41)
CXCL1, CCL3, CCL2, CXCL5, S100A8, C3, CXCL3, TLR1, CXCL2, TLR2, CCL5, CXCL11, CCL4, CCL7, CXCL10, CASP4, MYD88, CHIL1, IL1B, ZC3H12A, TNIP1, IL1A, GBP5, OLR1, LYN, C4B, IL27, HCK, NLRP3, IFI202B, CCL12, CXCL13, CLEC7A, TNFAIP3, CD14 C3, CASP1, CASP4, CASP8, CCL2, CCL5, CCRL2, CD274, CD40, CD86, CMPK2, CXCL10, CXCL11, CXCL9, EIF2AK2, FAM26F, FCGR1A, FGL2, GBP2, GBP3, GBP5, GBP6, HERC6, ICAM1, IFI16, IFI35, IFI47, IFIT1, IFIT1B, IFIT2, IFITM3, IGTP, IL15, IL15RA, IL1R1, IL6, ISG15, KLRK1, MX1/MX2, OAS1, OASL, PTGS2, RSAD2, SLFN1, SLFN13, SLFN2, SLFN5, SP110, TAP1, TGTP1, TGTP2, TLR9, TNF, TNFSF10, TRAFD1, USP18 CASP1, CCL5, CCL7, CD14, CD40, CEBPB, CEBPD, CLIC4, CXCL10, DTX2, FCGR2, GBP5, GCH1, GFAP, IFI47, IKB, IL12B, IL1B, IRAK2, LCN2, LILRB4, NLRP3, NOS2, MAPK, PLSCR1, PRKAA, PSME2, SERCA, SLC16A10, SLFN2, SPATA13, SUSD6, TANK, TNFA, TNFAIP2, TNFAIP3, TNFSF15, TNIP1, TRIP10 APOBEC3, LY86, TLR2, TLR3, TLR7, TLR9, ISG20, NLRC5, NOD2, TMEM173, CASP4, MYD88, NOD1, OASL2, OASL1, MX1, MX2, LYN, BST2, IFI202B, OAS1B, RIPK2, OAS1A, RNF135, EIF2AK2, IFIH1, C3, CSF1, IFITM3, PML, KLRK1, OAS3, RSAD2, SP110, OAS2, NAIP6, IRGM1, TRIM25, AIM2, DDX58, IFIT3, TRIM56, IFIT2, IFIT1